Porcheddu Rossella, Serra Caterina, Kelvin David, Kelvin Nikki, Rubino Salvatore
Freelance Journalist, JIDC Italy.
Dipartimento di Scienze Biomediche, Università degli Studi di Sassari, Sassari, Italy.
J Infect Dev Ctries. 2020 Feb 29;14(2):125-128. doi: 10.3855/jidc.12600.
As of 28 February 2020, Italy had 888 cases of SARS-CoV-2 infections, with most cases in Northern Italy in the Lombardia and Veneto regions. Travel-related cases were the main source of COVID-19 cases during the early stages of the current epidemic in Italy. The month of February, however, has been dominated by two large clusters of outbreaks in Northern Italy, south of Milan, with mainly local transmission the source of infections. Contact tracing has failed to identify patient zero in one of the outbreaks. As of 28 February 2020, twenty-one cases of COVID-19 have died. Comparison between case fatality rates in China and Italy are identical at 2.3. Additionally, deaths are similar in both countries with fatalities in mostly the elderly with known comorbidities. It will be important to develop point-of-care devices to aid clinicians in stratifying elderly patients as early as possible to determine the potential level of care they will require to improve their chances of survival from COVID-19 disease.
截至2020年2月28日，意大利有888例严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染病例，大多数病例集中在意大利北部的伦巴第大区和威尼托大区。在意大利当前疫情的早期阶段，与旅行相关的病例是新冠病毒病（COVID-19）病例的主要来源。然而，2月份意大利北部米兰以南出现了两起大型聚集性疫情，感染源主要是本地传播。在其中一起疫情中，接触者追踪未能确定零号病人。截至2020年2月28日，已有21例COVID-19病例死亡。中国和意大利的病死率相同，均为2.3%。此外，两国的死亡情况相似，死亡者大多是患有已知合并症的老年人。开发即时检测设备，以帮助临床医生尽早对老年患者进行分层，确定他们为提高从COVID-19疾病中存活的几率所需的潜在护理水平，这将非常重要。
